Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
2006 3
2007 4
2008 2
2009 2
2010 1
2011 1
2013 1
2014 1
2016 2
2018 1
2019 4
2020 1
2022 1
2023 2
2024 4
2025 4
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Multifunctional rGO/Y(2)O(3)@hydroxyapatite bioceramics: structural, optical, and biomedical properties.
Kamoun EA, Elawadly A, Emam MH, El-Moslamy SH, Elzayat AM, Abdelrazek EM, Sallah M, Son JY, Ali AI. Kamoun EA, et al. RSC Adv. 2026 Jan 23;16(6):5264-5280. doi: 10.1039/d5ra08618c. eCollection 2026 Jan 21. RSC Adv. 2026. PMID: 41584109 Free PMC article.
HAp/rGO/Y(2)O(3) composites were prepared by ethanol-assisted wet blending (colloidal dispersion), followed by drying and heat treatment, and systematically characterized. ...UV/visible spectroscopy showed a significant narrowing of the optical bandgap from 5.42 eV in pure …
HAp/rGO/Y(2)O(3) composites were prepared by ethanol-assisted wet blending (colloidal dispersion), followed by drying and heat treatm …
Effects of Flaxseed Interventions on Circulating Inflammatory Biomarkers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Rahimlou M, Jahromi NB, Hasanyani N, Ahmadi AR. Rahimlou M, et al. Adv Nutr. 2019 Nov 1;10(6):1108-1119. doi: 10.1093/advances/nmz048. Adv Nutr. 2019. PMID: 31115436 Free PMC article.
From the eligible trials, 32 articles describing studies conducted on adults aged 18-70 y were selected for the meta-analysis. Meta-analyses using the random-effects model were performed to investigate the data and results showed significant effects of flaxseed intake on c …
From the eligible trials, 32 articles describing studies conducted on adults aged 18-70 y were selected for the meta-analysis. Meta-a …
A consensus privacy metrics framework for synthetic data.
Pilgram L, Dankar FK, Drechsler J, Elliot M, Domingo-Ferrer J, Francis P, Kantarcioglu M, Kong L, Malin B, Muralidhar K, Myles P, Prasser F, Raisaro JL, Yan C, El Emam K. Pilgram L, et al. Patterns (N Y). 2025 Jul 29;6(10):101320. doi: 10.1016/j.patter.2025.101320. eCollection 2025 Oct 10. Patterns (N Y). 2025. PMID: 41142908 Free PMC article.
Bone density in transfusion dependent thalassemia patients in Urmia, Iran.
Valizadeh N, Farrokhi F, Alinejad V, Said Mardani S, Valizadeh N, Hejazi S, Noroozi M. Valizadeh N, et al. Iran J Ped Hematol Oncol. 2014;4(2):68-71. Epub 2014 Apr 20. Iran J Ped Hematol Oncol. 2014. PMID: 25002928 Free PMC article.
MATERIALS AND METHODS: In this cross sectional descriptive study,10 patients (lower than 18 y/o)with transfusion dependent thalassemia attending to Motahari and Emam Khomeini hospitals in Urmia city of Iran were enrolled and scanned for Bone Mineral Density (BMD) st …
MATERIALS AND METHODS: In this cross sectional descriptive study,10 patients (lower than 18 y/o)with transfusion dependent thalassemi …
Therapy-related second malignant neoplasms on top of neuroblastoma: frequency, types and risk factors.
Fawzy M, Abdelfattah N, Alaa M, Mohsen I, Soliman S, Salem S, Zekri W, Arafah O. Fawzy M, et al. Discov Oncol. 2025 May 21;16(1):851. doi: 10.1007/s12672-025-02661-6. Discov Oncol. 2025. PMID: 40397208 Free PMC article.
Age at neuroblastoma diagnosis ranged from 6 mo to 9.5 y (median age: 2 y) with male to female ratio of 1.2:1. Time to development of hematological treatment-related SMN was 14 mo to 8.3 y (mean: 3.7 y) versus 5.5-9.2 y (mean: 7.6 y) for …
Age at neuroblastoma diagnosis ranged from 6 mo to 9.5 y (median age: 2 y) with male to female ratio of 1.2:1. Time to develop …
32 results